These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9247762)

  • 1. Aldosterone, salt and cardiac fibrosis.
    Funder JW
    Clin Exp Hypertens; 1997; 19(5-6):885-99. PubMed ID: 9247762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptors and hypertension.
    Funder JW
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):53-5. PubMed ID: 7626506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone and mineralocorticoid receptors: orphan questions.
    Funder JW
    Kidney Int; 2000 Apr; 57(4):1358-63. PubMed ID: 10760067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
    Young MJ; Moussa L; Dilley R; Funder JW
    Endocrinology; 2003 Mar; 144(3):1121-5. PubMed ID: 12586788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension.
    Gómez-Sánchez EP; Fort CM; Gómez-Sánchez CE
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E482-4. PubMed ID: 2316642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone action: fact, failure and the future.
    Funder JW
    Clin Exp Pharmacol Physiol Suppl; 1998 Nov; 25():S47-50. PubMed ID: 9809192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.
    Qin W; Rudolph AE; Bond BR; Rocha R; Blomme EA; Goellner JJ; Funder JW; McMahon EG
    Circ Res; 2003 Jul; 93(1):69-76. PubMed ID: 12791709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes.
    Sato A; Funder JW
    Endocrinology; 1996 Oct; 137(10):4145-53. PubMed ID: 8828470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
    Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
    Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats.
    Huang BS; White RA; Jeng AY; Leenen FH
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R994-R1000. PubMed ID: 19118098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptors, salt, and hypertension.
    Funder JW; Krozowski Z; Myles K; Sato A; Sheppard KE; Young M
    Recent Prog Horm Res; 1997; 52():247-60; discussion 261-2. PubMed ID: 9238855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
    Lavall D; Selzer C; Schuster P; Lenski M; Adam O; Schäfers HJ; Böhm M; Laufs U
    J Biol Chem; 2014 Mar; 289(10):6656-6668. PubMed ID: 24469458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action.
    Funder JW; Pearce PT; Myles K; Roy LP
    FASEB J; 1990 Nov; 4(14):3234-8. PubMed ID: 2172062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
    Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Hypertension; 2001 Oct; 38(4):902-6. PubMed ID: 11641306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system.
    Mihailidou AS; Funder JW
    Steroids; 2005; 70(5-7):347-51. PubMed ID: 15862816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats.
    Yasuoka S; Kai H; Kajimoto H; Kudo H; Takayama N; Anegawa T; Koga M; Miyamoto T; Mifune H; Kage M; Hirooka Y; Imaizumi T
    Circ J; 2013; 77(6):1474-81. PubMed ID: 23470864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.
    Wang HW; Huang BS; Chen A; Ahmad M; White RA; Leenen FH
    Neuroscience; 2016 Feb; 314():90-105. PubMed ID: 26656220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.
    Young M; Head G; Funder J
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E657-62. PubMed ID: 7485478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.